GlassScriptPhysician profile
Erin T White
NPI 1386166288
$4,950.07
in general payments reported to CMS, 2019-2025
35 companies · $697 in 2025
The $697 reported for 2025 was more than what 82% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $565 · 2022: $963 · 2023: $1,580 · 2024: $1,145 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,352 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,352.41 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $762.82 | 2021-2025 | Farxiga, Lokelma, Wainua |
| Novartis Pharmaceuticals Corporation | $608.75 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $432.79 | 2022-2025 | Lifevest |
| Amgen INC. | $392.35 | 2021-2024 | Repatha |
| Abbott Laboratories | $342.02 | 2021-2023 | Mitraclip, Amplatzer Amulet |
| Merck Sharp & Dohme LLC | $232.46 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $209.22 | 2021-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $182.70 | 2022-2025 | Watchman Access System, Watchman Flx |
| Baxter Healthcare | $172.67 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $159.55 | 2023-2024 | Opsumit, Uptravi |
| Novo Nordisk INC | $135.16 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $128.19 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $118.76 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $112.34 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.61 | 2023-2024 | Jardiance |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $90.22 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $80.54 | 2021 | |
| Inspire Medical Systems, INC. | $77.70 | 2024-2025 | Inspire |
| Edwards Lifesciences Corporation | $59.41 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Irhythm Technologies, INC. | $58.90 | 2022-2023 | Zio Xt Patch |
| Esperion Therapeutics, INC. | $58.17 | 2021-2025 | Nexletol |
| Medicomp INC | $54.99 | 2024 | Telepatch Cardiac Monitor |
| Kestra Medical Technology Services, INC. | $52.76 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $47.40 | 2024 | Arcalyst |
| Atricure, INC. | $42.62 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $38.12 | 2022-2023 | Arcalyst |
| Philips North America LLC | $34.67 | 2023-2024 | (Ck4) Mcot |
| Daiichi Sankyo INC. | $24.65 | 2023 | Injectafer |
| Lantheus Medical Imaging, INC. | $23.82 | 2023 | Definity |
| Heartflow, INC. | $23.33 | 2025 | |
| Alnylam Pharmaceuticals INC. | $22.25 | 2025 | Onpattro |
| Chiesi USA, INC. | $21.88 | 2025 | Kengreal |
| Bayer Healthcare Pharmaceuticals INC. | $21.82 | 2022 | |
| Medtronic, INC. | $21.71 | 2024 | Symplicity G3 |
| Regeneron Healthcare Solutions, INC. | $14.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.